BRETYLIUM TOSYLATE INJECTION USP
SANDOZ CANADA INCORPORATED
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is BRETYLIUM TOSYLATE INJECTION USP discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that BRETYLIUM TOSYLATE INJECTION USP has been permanently discontinued (last updated April 1, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is BRETYLIUM TOSYLATE INJECTION USP not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
BRETYLATE INJ 50MG/ML
GLAXO WELLCOME INC.
BRETYLIUM TOSYLATE INJ 50MG/ML
ABBOTT LABORATORIES, LIMITED
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02185377
Compare with another product →
Shortage History
Business reasons
Manufacturing issues
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495910
DIN 02495937
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759